Protective effects of cyproheptadine on cerebral ischemia reperfusion injury in rats
Jian Liang
Abstract
Jian Liang
Abstract
Acute cerebral ischemia reperfusion injury was produced by reversible middle artery occlusion without craniectomy in rats. Cyproheptadine (Cyp) 1.5 and 2 mg·kg -1 iv decreased the size of cerebral infarction after ischemia for 2 h followed by reperfusion for 3 h. Cyp (2 mg·kg -1 iv) improved brain electrical activity, increased the activity of superoxide dismutase, and decreased the content of malondialdehyde in brain. These results indicate that Cyp has protective effects against cerebral ischemia- reperfusion injury, probably through inhibiting free radical and subsequent lipid peroxidation.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Acute cerebral ischemia reperfusion injury was produced by reversible middle artery occlusion without craniectomy in rats. Cyproheptadine (Cyp) 1.5 and 2 mg·kg -1 iv decreased the size of cerebral infarction after ischemia for 2 h followed by reperfusion for 3 h. Cyp (2 mg·kg -1 iv) improved brain electrical activity, increased the activity of superoxide dismutase, and decreased the content of malondialdehyde in brain. These results indicate that Cyp has protective effects against cerebral ischemia- reperfusion injury, probably through inhibiting free radical and subsequent lipid peroxidation.
Key concepts: Ischemia, Malondialdehyde, Cyproheptadine, Lipid peroxidation, Superoxide dismutase, Reperfusion injury, Pharmacology, Medicine